Interactions between cancer cells, immune, and non-immune cells in the tumor microenvironment as well as the spatial distribution of complement proteins add complexity to multifaced roles of complement in cancer and present a significant challenge to develop therapy. The gene discussed is VTN; the disease is cancer.